UBS ASSET MANAGEMENT AMERICAS INC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 162 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,027,985
+89.5%
50,170
+58.4%
0.00%
Q2 2023$542,5250.0%31,6710.0%0.00%
Q1 2023$542,525
-48.2%
31,671
-40.8%
0.00%
-100.0%
Q4 2022$1,046,428
-99.8%
53,471
+36.6%
0.00%
Q3 2022$624,642,000
+16.0%
39,1380.0%0.00%
Q2 2022$538,538,000
-13.2%
39,1380.0%0.00%
Q1 2022$620,728,000
-27.3%
39,1380.0%0.00%
Q4 2021$854,382,000
-39.8%
39,138
-17.6%
0.00%
-100.0%
Q3 2021$1,419,179,000
-34.4%
47,480
-2.8%
0.00%0.0%
Q2 2021$2,163,656,000
+30.6%
48,852
+30.8%
0.00%0.0%
Q1 2021$1,656,777,000
-14.8%
37,340
+5.3%
0.00%0.0%
Q4 2020$1,945,229,000
+139.9%
35,4710.0%0.00%
Q3 2020$810,868,000
+23.4%
35,471
+13.0%
0.00%
Q2 2020$657,013,000
+206.6%
31,391
+233.5%
0.00%
Q4 2019$214,262,000
+14.8%
9,414
-24.3%
0.00%
Q2 2019$186,570,00012,4380.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders